Dr. Wang has a strong academic background and broad research collaboration network worldwide and holds >130 peer-reviewed publications on prestigious journals and numerous international conference presentations. Her specialized areas include IBD, fecal transplantation, and immunotherapy GI toxicities.  

Dr. Wang served as the chair of MD Anderson immunotherapy toxicity working group and is recognized internationally for her expertise in managing immunotherapy induced GI toxicities. She served as guideline panel member in ASCO, NCCN, ESMO, AGA, SITC, UPTODATE, and recently contributed a new book entitled “Managing Immunotherapy Related Organ Toxicities, A Practical Guide” as the editor. Dr. Wang’s group achieved multiple breakthroughs of successful treatment for immunotherapy induced colitis and run multiple clinical trials at MD Anderson.